Table 5.
Association of Physician Gender and Prostate Cancer Prevention Attitudes and Practices*
| Item | Percent Distribution
|
P Value† | |
|---|---|---|---|
| Female | Male | ||
| PSA 40–49 y old | .483 | ||
| Every year | 22.4 | 21.8 | |
| Every 2 to 3 y | 24.5 | 24.7 | |
| Every 5 y | 8.8 | 13.6 | |
| Do not recommend | 44.2 | 40.0 | |
| PSA 50–69 y | .508 | ||
| Every year | 77.5 | 81.4 | |
| Every 2 to 3 y | 12.6 | 11.9 | |
| Every 5 y | 1.3 | 1.4 | |
| Do not recommend | 8.6 | 5.2 | |
| PSA 70 to 79 y | .475 | ||
| Every year | 70.9 | 73.6 | |
| Every 2 to 3 y | 10.8 | 13.2 | |
| Every 5 y | 1.4 | 1.0 | |
| Do not recommend | 16.9 | 12.3 | |
| PSA 80+ y | .976 | ||
| Every year | 46.0 | 48.1 | |
| Every 2 to 3 y | 10.7 | 10.6 | |
| Every 5 y | 2.0 | 1.9 | |
| Do not recommend | 41.3 | 39.4 | |
| PSA effective | <.005 | ||
| Extremely/very effective | 28.4 | 40.8 | |
| Quite effective | 47.7 | 29.2 | |
| Somewhat effective | 29.7 | 23.0 | |
| A little/not effective at all | 14.2 | 7.0 | |
*
PSA indicates prostate-specific antigen.
†
Two-sided P value from χ2 tests for comparison of proportions.
Bold indicates p < 0.05.